Loading, please wait...
.webp&w=384&q=75){kind=logo}
Verifying...
Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates
Recent research into the Pathogen Hypothesis of Alzheimer's examines how infectious agents might contribute to dementia. While the 2024 Lancet Commission identified 14 modifiable risk factors, it omitted pathogens due to causality debates. However, new quantitative analyses suggest that viruses and bacteria play a significant role in neuroinflammation and amyloidogenesis.
Researchers utilized nationwide cohort studies to apply a Population Attributable Fraction (PAF) model. This study specifically evaluated pathogens such as Herpes Simplex Virus Type 1 (HSV-1), Porphyromonas gingivalis, and Chlamydia pneumoniae. Findings suggest that infectious agents could account for 19% to 31% of cases in single-pathogen models. In joint models of sporadic cases, this burden expands to a range of 31% to 52%.
The study also highlights a synergistic interaction with the APOE ε4 allele. Furthermore, investigators addressed failures in antimicrobial clinical trials like VALAD and GAIN. They argue that these results demonstrate a need for precision biomarker stratification rather than a refutation of the hypothesis. Consequently, integrating pathogen suppression into prevention protocols may be vital for future care.
Key pathogens include Herpes Simplex Virus Type 1 (HSV-1), Porphyromonas gingivalis (associated with gum disease), and Chlamydia pneumoniae.
Experts suggest these trials likely failed because they lacked precision biomarker stratification to identify patients most likely to benefit from treatment.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Bender O et al. Beyond association: A quantitative analysis of the infectious burden in Alzheimer's disease. J Alzheimers Dis. 2026 May 11. doi: 10.1177/13872877261447530. PMID: 42115784.
Livingston G et al. Dementia prevention, intervention, and care: 2024 report of the Lancet Commission. Lancet. 2024 Aug 10;404(10452):572-628. doi: 10.1016/S0140-6736(24)01296-0.
Itzhaki RF et al. Microbes and Alzheimer's Disease. J Alzheimers Dis. 2016;51(4):979-84. doi: 10.3233/JAD-160152.
Link will be sent via SMS to your number.
New quantitative models suggest infectious pathogens contribute significantly to Alzheimer's disease burden, potentially accounting for up to 52% of cases....
4 weeks back
A new modeling study from Spain reveals that increasing nirmatrelvir/ritonavir utilization in high-risk COVID-19 outpatients could reduce hospitalizations and deaths by up to 47%. The findings highlight significant clinical and societal benefits, including reduced ICU strain and lower productivity losses.
Today
A case-control study identifies key determinants of obstructed labor, such as gestational diabetes, maternal BMI, and late referrals. Understanding these factors is crucial for enhancing maternal care and reducing mortality in high-burden settings.
Today
This retrospective study evaluates the correlation of Lp-PLA2 and Ang II levels with coronary artery stenosis severity in elderly patients. Findings suggest these biomarkers are independent risk factors for moderate-to-severe stenosis, providing diagnostic performance comparable to the atherogenic index.
Today
A prospective study (SCOL Study) evaluates how different levels of anesthesia depth (BIS 60 vs 40) impact motor evoked potentials (TcMEP) in youths. Findings suggest that while deeper anesthesia alters signal parameters, it does not hinder successful surgeon-directed interpretation.
Today
A study of 66,785 US hospitalizations reveals a significant rise in intensive nutritional interventions and restraints for Anorexia Nervosa. Use of nasogastric tubes and physical restraints increased from 2017 to 2022, highlighting the need for clearer clinical ethics and less coercive care alternatives.
Today